Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00864916 · ClinicalTrials.gov registry record · Phase 2
Pentoxifylline and Combination Antiretroviral Therapy to Improve Blood Vessel Function in HIV-Infected People
A Phase 2 study, sponsored by Indiana University.
- Completed
- Registry status
- Phase 2
- Development phase
- 19
- Enrollment target
NCT00864916 is a Phase 2 study that has completed, run by Indiana University. The registered enrollment target is 19 participants.
The verdict
NCT00864916, a Phase 2 study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 19 participants
- Enrollment target
Study Summary
People infected with HIV have a greater risk of developing cardiovascular disease than people not infected with HIV. This may be due to increased inflammation in the blood vessels. This study will determine whether an anti-inflammatory drug, pentoxifylline, in combination with antiretroviral medications, is more effective at improving blood vessel function and reducing inflammation than antiretroviral medications alone in people infected with HIV.
Interventions
- DRUG Placebo
- DRUG Pentoxifylline
- DRUG Combination antiretroviral therapy (cART)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2009-03 |
| Est. Completion | 2012-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00864916
The ClinicalTrials.gov registry entry for NCT00864916 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT00864916 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00864916 about?
NCT00864916 is a clinical study titled "Pentoxifylline and Combination Antiretroviral Therapy to Improve Blood Vessel Function in HIV-Infected People". People infected with HIV have a greater risk of developing cardiovascular disease than people not infected with HIV. This may be due to increased inflammation in the blood vessels. This study will determine whether an anti-inflammatory drug, pentoxifylline, in combination with antiretroviral medicat...
What is the current status of trial NCT00864916?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 19 participants. The study started on 2009-03. Estimated completion is 2012-12.
What interventions are being tested in trial NCT00864916?
The interventions under investigation include: Placebo (DRUG), Pentoxifylline (DRUG), Combination antiretroviral therapy (cART) (DRUG).
Who is sponsoring clinical trial NCT00864916?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.